Latest News and Press Releases

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDERRULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANTSECURITIES...

Operational Highlights April Occupancy reached 73%, up 4% from last April, with one more roundtrip this year. Cabin nights increased by 18%.Average Cabin Revenue (ACR) increased by 1% compared to...

Director / PDMR Shareholding Serabi announces that on 12 May 2026 the Board of Directors agreed to award in aggregate 458,114 Conditional Share Awards (“CSA’s”) to employees (including directors) of...

Vesting and settlement of 2023 Conditional Share Awards and Notification of transactions by persons discharging managerial responsibilities Serabi announces that on 12 May 2026 the Board of...

Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 13. May 2026 / 08:58 CET/CEST, transmitted by...

Renk Group AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung 13. May 2026 / 08:58 CET/CEST, übermittelt von GlobeNewswire. Für den Inhalt der...

COMPANY ANNOUNCEMENT NO. 25-2026FLSmidth & Co. A/S13 May 2026Copenhagen, Denmark FLSmidth & Co. A/S (‘FLSmidth’) today announces the implementation of share-based incentive programmes for...

Daix (France), New York City (New York, United States), May 13, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Daix (France), New York City (New York, Etats-Unis), le 13 mai 2026 – Inventiva (Euronext Paris et NASDAQ: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique au stade clinique...

AB “Ignitis grupė” (hereinafter – the Group) publishes its Strategic Plan 2026–2029, which is attached to this notice. The Group continues to implement its ambitious strategy with the purpose to...